Ping-Chih Hsu Selected Research

ceritinib

12/2019

Front-line treatment of ceritinib improves efficacy over crizotinib for Asian patients with anaplastic lymphoma kinase fusion NSCLC: The role of systemic progression control.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ping-Chih Hsu Research Topics

Disease

27	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 08/2016
26	Neoplasms (Cancer) 01/2024 - 10/2015
17	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2018
16	Adenocarcinoma of Lung 02/2023 - 01/2014
9	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2017
4	Carcinogenesis 05/2020 - 01/2017
3	Diarrhea 01/2024 - 12/2019
3	Malignant Mesothelioma 12/2018 - 11/2017
3	Mesothelioma 11/2017 - 10/2015
2	Mucositis 01/2024 - 02/2023
2	Paronychia 01/2024 - 02/2021
2	Dermatitis 02/2023 - 12/2021
2	Body Weight (Weight, Body) 01/2023 - 11/2017
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2022 - 01/2022
2	Disease Progression 01/2022 - 12/2019
2	Aneuploidy (Aneuploid) 01/2022 - 01/2020
2	Infections 02/2021 - 01/2021
1	COVID-19 03/2024
1	Inflammation (Inflammations) 03/2024
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 03/2024
1	Thrombotic Microangiopathies 01/2023
1	Proteinuria 01/2023
1	Sarcopenia 01/2023
1	Circulating Neoplastic Cells 09/2022
1	Sepsis (Septicemia) 04/2022
1	Liver Neoplasms (Liver Cancer) 01/2022
1	Obstructive Lung Diseases (Obstructive Lung Disease) 10/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 10/2021
1	Drug Eruptions (Drug Eruption) 07/2021
1	Pain (Aches) 02/2021
1	Asthma (Bronchial Asthma) 01/2021
1	Drug-Related Side Effects and Adverse Reactions 01/2021
1	Pneumonia (Pneumonitis) 11/2018
1	Brain Neoplasms (Brain Tumor) 01/2018

Drug/Important Bio-Agent (IBA)

28	ErbB Receptors (EGF Receptor)IBA 01/2024 - 01/2014
16	Tyrosine Kinase InhibitorsIBA 01/2024 - 01/2014
15	AfatinibIBA 01/2024 - 11/2017
13	Proteins (Proteins, Gene)FDA Link 07/2022 - 10/2015
8	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2024 - 08/2016
7	Bevacizumab (Avastin)FDA Link 01/2023 - 10/2020
6	B7-H1 AntigenIBA 01/2023 - 12/2017
6	Small Interfering RNA (siRNA)IBA 01/2022 - 10/2015
3	Gefitinib (Iressa)FDA Link 01/2024 - 11/2017
3	Immune Checkpoint InhibitorsIBA 01/2023 - 08/2019
2	CadmiumIBA 03/2024 - 10/2021
2	osimertinibIBA 01/2024 - 10/2022
2	PlatinumIBA 01/2023 - 12/2019
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 07/2022 - 01/2022
2	durvalumabIBA 10/2021 - 01/2020
2	Epidermal Growth Factor (EGF)IBA 07/2021 - 11/2017
2	SolutionsIBA 07/2021 - 02/2021
2	Verteporfin (Visudyne)FDA Link 01/2017 - 08/2016
1	CreatinineIBA 03/2024
1	Interleukin-6 (Interleukin 6)IBA 03/2024
1	C-Reactive ProteinIBA 03/2024
1	NickelIBA 03/2024
1	Methionine (L-Methionine)FDA Link 01/2024
1	Codon (Codons)IBA 01/2024
1	Threonine (L-Threonine)FDA Link 01/2024
1	ZincIBA 02/2023
1	NivolumabIBA 01/2023
1	Carboplatin (JM8)FDA LinkGeneric 01/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 09/2022
1	Local Anti-Infective Agents (Antiseptics)IBA 04/2022
1	chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric 04/2022
1	Povidone-Iodine (Betadine)FDA LinkGeneric 04/2022
1	CateninsIBA 01/2022
1	napabucasinIBA 01/2022
1	Oxygen (Dioxygen)IBA 10/2021
1	Dicloxacillin (Dycill)FDA LinkGeneric 07/2021
1	Betaxolol (Kerlon)FDA LinkGeneric 02/2021
1	Antineoplastic Agents (Antineoplastics)IBA 02/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	InterferonsIBA 01/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2020
1	Growth Factor ReceptorsIBA 05/2020
1	Delta CateninIBA 01/2020
1	LumicanIBA 01/2020
1	CrizotinibIBA 12/2019
1	ceritinibIBA 12/2019
1	Anaplastic Lymphoma KinaseIBA 12/2019
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 08/2019
1	TriterpenesIBA 08/2019
1	cucurbitacin EIBA 08/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2019
1	atezolizumabIBA 11/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Membrane Proteins (Integral Membrane Proteins)IBA 12/2017

Therapy/Procedure

20	Therapeutics 02/2023 - 04/2016
7	Drug Therapy (Chemotherapy) 01/2024 - 01/2014
5	Immunotherapy 06/2021 - 01/2018
2	Radiotherapy 01/2019 - 01/2018
1	Artificial Respiration (Mechanical Ventilation) 03/2024
1	Drug Tapering 01/2023
1	Catheters 04/2022
1	Central Venous Catheters 04/2022
1	Patient Care Bundles 04/2022
1	Chemoradiotherapy 01/2019